These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11215111)

  • 1. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular-epidemiological evaluation of Serratia marcescens isolates from patient specimens in one Japanese hospital during the three years from April 1999 to March 2002].
    Marumo K; Nakamura Y
    Rinsho Byori; 2003 Dec; 51(12):1174-9. PubMed ID: 14743739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation rate of non-hemagglutinating strains of Serratia marcescens from clinical specimens in a general hospital: comparison of serotypes O2 and O14.
    Yanagawa Y; Marumo K; Nakamura Y; Shimamura T
    J Infect Chemother; 2007 Jun; 13(3):151-6. PubMed ID: 17593501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation of Serratia marcescens from patient specimens in one Japanese hospital between April 2002 and March 2004].
    Marumo K; Taguchi K
    Rinsho Byori; 2005 Sep; 53(9):787-92. PubMed ID: 16235830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological markers of Serratia marcescens isolates causing nosocomial infections in Spain (1981-1991).
    Boquete T; Vindel A; Martin-Bourgon C; Azañedo L; Sáez-Nieto JA
    Microbiologia; 1996 Dec; 12(4):607-12. PubMed ID: 9018695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [O-serotypes, biotypes, and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens: 3rd report].
    Marumo K; Nagaki T; Nakamura Y
    Rinsho Byori; 1992 Dec; 40(12):1312-8. PubMed ID: 1307637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of Serratia marcescens between 1987 and 1995 at Vall d'Hebron Hospital].
    Royo P; del Valle O; Boquete T
    Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):519-27. PubMed ID: 9522516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.
    Hejazi A; Aucken HM; Falkiner FR
    J Hosp Infect; 2000 May; 45(1):42-6. PubMed ID: 10833342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
    J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of chlorhexidine gluconate on Serratia marcescens clinical isolates: relevance to serotype O3].
    Marumo K; Nakamura Y
    Rinsho Byori; 1994 Jul; 42(7):731-6. PubMed ID: 8065040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.